查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587585

骨形成蛋白市場規模、佔有率、趨勢分析報告：按類型、應用、區域、細分市場預測，2025-2030

Bone Morphogenetic Protein Market Size, Share & Trends Analysis Report By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

骨形成蛋白市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球骨形成蛋白市場規模將達到4.599億美元，2025年至2030年複合年成長率為4.93%。

脊椎融合手術、創傷、聽骨手術發生率的增加以及對更快骨骼恢復的需求是確保 BMP 市場成長的主要因素。

腰痛和椎間盤脫位是最常見的職業病。超過 75% 的此類疾病無法透過非侵入性治療方法緩解，需要進行脊椎手術。微創手術、縮短住院時間、加速復原速度是患者的普遍訴求。由於上述優點，BMP近年來受到骨科醫生的歡迎。

運動相關損傷、老年人口的增加以及骨誘導產品作為骨移植替代品的認知不斷提高也是推動市場成長的因素。據報導，BMP 的結果優於骨移植，包括無捐贈者發病率、廣泛的外科手術、恢復時間長、疼痛和麻木以及高成本。

骨形成蛋白市場報告亮點：

  • rhBMP-2和rhBMP-7是市售的重組BMP。 rhBMP-2 因其高度骨誘導特性而廣為人知，可在骨融合手術中加速骨骼和軟骨的形成。
  • rhBMP-2 細分市場在 2024 年佔據最大市場佔有率，達到 73.9%，預計 2025 年至 2030 年將以更高的複合年成長率成長。
  • rhBMP-7 細分市場預計從 2025 年到 2030 年將以適度的複合年成長率成長。隨著醫療保健專業人員擴大尋求自體移植骨骼修復的替代品，rhBMP-7 促進癒合且沒有與移植物收穫相關的併發症的能力將促進其在臨床環境中的採用。
  • 脊椎融合手術領域佔最大市場佔有率，2024年將達50.3%。這種成長是由有效和高效的解決方案的開發、這些蛋白質相對於傳統治療方法的接受度的提高以及旨在加強其市場地位的持續研究舉措所推動的。
  • 2024年，北美在全球骨形成蛋白市場中佔據最大市場佔有率，達到49.6%。最大的市佔率歸因於整形外科手術量大和有利的報銷政策。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章骨形成蛋白市場：按類型進行的業務分析

  • 類型細分儀表板
  • 全球骨形成蛋白市場類型波動分析
  • 2018-2030年全球骨形成蛋白市場規模及趨勢分析（依類型）
  • 重組HBMP-2基因
  • 重組HBMP-7基因

第5章骨形成蛋白市場：應用業務分析

  • 使用細分儀表板
  • 全球骨形成蛋白市場應用變化分析
  • 2018-2030年全球骨形成蛋白市場規模及趨勢分析（依應用）
  • 脊椎融合手術
  • 創傷
  • 重組
  • 口腔顎顏面

第6章骨形成蛋白市場：按類型和應用分類的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與企業
  • 策略規劃
  • 2024 年企業市場分析
  • 參與企業概況
    • Medtronic plc
    • Cellumed Co., Ltd.
    • Cell Guidance Systems LLC
    • Merck KGaA
    • Prospec-Tany Technogene Ltd.
    • Qkine Ltd.
    • Bio-Techne.
    • Thermo Fisher Scientific Inc.
    • Proteintech Group, Inc.
    • STEMCELL Technologies
    • Sartorius Stedim Biotech
Product Code: GVR-1-68038-226-6

Bone Morphogenetic Protein Market Growth & Trends:

The global bone morphogenetic protein market size is expected to reach USD 459.9 million by 2030, registering a CAGR of 4.93% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of spinal fusion, trauma, and small bone surgeries coupled with demand for faster bone recovery are the key drivers affirming growth of BMP market.

Low back pain and spinal disc dislocation are some of the most common occupational hazards. Over 75% of such disorders require spinal surgery after noninvasive treatment options are unable to provide any relief. Minimally invasive surgery, shorter hospital stays, and fast recovery are common demands observed among patients. BMP has gained high acceptance among orthopedic surgeons in recent years owing to its ability to cater above mentioned benefits

Sport-related injuries, growing geriatric population, and increasing awareness about osteoinduction products as an alternative to bone grafting are other drivers accentuating market growth. BMP has reported outstanding results over bone graft, such as lack of donor morbidity, extensive surgical procedure, higher recovery time, pain & numbness, and high cost.

Bone Morphogenetic Protein Market Report Highlights:

  • rhBMP-2 and rhBMP-7 are the commercially available recombinant BMPs. rhBMP-2 is widely known for its high osteoinductive property for faster formation of bone and cartilage in bone fusion procedures.
  • The rhBMP-2 segment held the largest market share of 73.9% in 2024 and is anticipated to grow at the higher CAGR from 2025 to 2030.
  • rhBMP-7 segment is expected to grow at a moderate CAGR from 2025 to 2030. As healthcare professionals increasingly look for alternatives to autografts for bone repair, rhBMP-7's ability to promote healing without the complications associated with harvesting grafts could drive its adoption in clinical practice.
  • The spinal fusion segment held the largest market share of 50.3% in 2024. The growth is attributed to the development of effective and efficient solutions, the increasing acceptance of these proteins over conventional treatments, and the ongoing research initiatives that strengthen their position in the market.
  • North America held the largest market share of 49.6% in the global bone morphogenetic protein market in 2024. High number of orthopedic surgical procedures, and availability of favorable reimbursement policies are drivers that can be attributed to for largest share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for minimally invasive medical procedures
      • 3.2.1.2. Increasing incidence of sports-related injuries
      • 3.2.1.3. Increasing target population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complications associated with the use of Bone Morphogenic Proteins
      • 3.2.2.2. Availability of alternative treatments
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bone Morphogenetic Protein Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global Bone Morphogenetic Protein Market Type Movement Analysis
  • 4.3. Global Bone Morphogenetic Protein Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. rhBMP-2
    • 4.4.1. Global rhBMP-2 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. rhBMP-7
    • 4.5.1. Global rhBMP-7 Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bone Morphogenetic Protein Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Bone Morphogenetic Protein Market Application Movement Analysis
  • 5.3. Global Bone Morphogenetic Protein Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Spinal Fusion
    • 5.4.1. Global Spinal Fusion Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Trauma
    • 5.5.1. Global TraumaMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Reconstruction
    • 5.6.1. Global Reconstruction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Oral Maxillofacial
    • 5.7.1. Global Oral Maxillofacial Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bone Morphogenetic Protein Market: Regional Estimates & Trend Analysis by Type and Application

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. North America Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Market and Competitive Scenario
      • 6.3.2.3. U.S. Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Market and Competitive Scenario
      • 6.3.3.3. Canada Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Market and Competitive Scenario
      • 6.3.4.3. Mexico Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Market and Competitive Scenario
      • 6.4.2.3. UK Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Market and Competitive Scenario
      • 6.4.3.3. Germany Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Market and Competitive Scenario
      • 6.4.4.3. France Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Market and Competitive Scenario
      • 6.4.5.3. Italy Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Market and Competitive Scenario
      • 6.4.6.3. Spain Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Market and Competitive Scenario
      • 6.4.7.3. Denmark Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Market and Competitive Scenario
      • 6.4.8.3. Sweden Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Market and Competitive Scenario
      • 6.4.9.3. Norway Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Market and Competitive Scenario
      • 6.5.2.3. Japan Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Market and Competitive Scenario
      • 6.5.3.3. China Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Market and Competitive Scenario
      • 6.5.4.3. India Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Market and Competitive Scenario
      • 6.5.5.3. Australia Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Market and Competitive Scenario
      • 6.5.6.3. Thailand Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Market and Competitive Scenario
      • 6.5.7.3. South Korea Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Market and Competitive Scenario
      • 6.6.2.3. Brazil Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Market and Competitive Scenario
      • 6.6.3.3. Argentina Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Market and Competitive Scenario
      • 6.7.2.3. South Africa Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Market and Competitive Scenario
      • 6.7.3.3. Saudi Arabia Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Market and Competitive Scenario
      • 6.7.4.3. UAE Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Market and Competitive Scenario
      • 6.7.5.3. Kuwait Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Participant's Overview
    • 7.4.1. Medtronic plc
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Cellumed Co., Ltd.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Cell Guidance Systems LLC
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Merck KGaA
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Prospec-Tany Technogene Ltd.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Qkine Ltd.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Bio-Techne.
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Thermo Fisher Scientific Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Proteintech Group, Inc.
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. STEMCELL Technologies
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Sartorius Stedim Biotech
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global Bone Morphogenetic Protein market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 13 Mexico Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 15 Europe Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 18 UK Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 20 Germany Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 22 France Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 23 France Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 24 Italy Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 25 Italy Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 26 Spain Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 27 Spain Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 28 Denmark Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 29 Denmark Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 30 Sweden Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 31 Sweden Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 32 Norway Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 33 Norway Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 37 Japan Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 38 Japan Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 39 China Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 40 China Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 41 India Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 42 India Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 43 Australia Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 44 Australia Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 45 Thailand Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 46 Thailand Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 47 South Korea Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 48 South Korea Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 49 Latin America Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 51 Latin America Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 52 Brazil Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 53 Brazil Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 54 Argentina Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 59 South Africa Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 63 UAE Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 64 UAE Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 65 Kuwait Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 67 Participant's overview
  • Table 68 Financial performance

List of Figures

  • Fig. 1 Bone Morphogenetic Protein market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Bone Morphogenetic Protein market driver analysis
  • Fig. 12 Bone Morphogenetic Protein market restraint analysis
  • Fig. 13 Bone Morphogenetic Protein market: Porter's analysis
  • Fig. 14 Bone Morphogenetic Protein market: PESTEL analysis
  • Fig. 15 Bone Morphogenetic Protein market: Type outlook and key takeaways
  • Fig. 16 Bone Morphogenetic Protein market: Type market share analysis, 2023 - 2030
  • Fig. 17 rhBMP-2 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 rhBMP-7 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Bone Morphogenetic Protein market: Application outlook and key takeaways
  • Fig. 20 Bone Morphogenetic Protein market: Application market share analysis, 2023 - 2030
  • Fig. 21 Spinal Fusion market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Trauma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Recontructive market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Oral Maxillofacial market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 North America Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Bone Morphogenetic Protein market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Europe Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 UK Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Germany Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 France Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Italy Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Spain Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Norway Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Asia-Pacific Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Japan Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 China Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 India Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Australia Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 MEA Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Key company categorization
  • Fig. 55 Company market positioning
  • Fig. 56 Market participant categorization
  • Fig. 57 Strategy framework